Race Oncology Limited
RAONF News Today: Stay Updated with the Latest Race Oncology Limited News in Real Time
Find RAONF news now at Meyka AI. Stay informed with the latest Race Oncology Limited stocks updates, including price news, market analysis, and expert insights.
MTARTECH.BO surges 21.9% on BSE after hours, April 30 2026
MTARTECH.BO stock jumps 21.9% to INR 6,450.8 in after-hours trading on BSE. MTAR Technologies gains momentum with strong technical signals.
CVLT Maintained at Sector Perform by Scotiabank, April 2026
Scotiabank maintains CVLT at Sector Perform, raises price target to $110 from $105 on April 29, 2026.
LMT.SW Stock Bounces 3.76% on April 30 as Defense Sector Stabilizes
LMT.SW stock rises 3.76% to CHF463.49 on SIX exchange. Lockheed Martin shows oversold bounce signals amid defense sector volatility.
Tech Earnings: Alphabet, Amazon Beat Meta in AI Race During Earnings Season
The latest Tech Earnings season has made one thing clear. Artificial Intelligence (AI) is now the main battleground for Big Tech. Companies are no longer competing only on revenue or users. They are competing on AI power. In this earnings cycle, Alphabet and Amazon clearly moved ahead. Meanwhile, Meta Platforms delivered strong results but failed…
8395.HK Stock Surges 46% as Qi-House Holdings Leads High Volume Trading
ZXZN Qi-House Holdings (8395.HK) jumps 46% on 4.6M volume. Furniture retailer shows strong momentum on HKSE with HK$0.46 price.
TEX Earnings Preview: Terex Reports May 1, EPS Estimate $0.78
Terex (TEX) earnings preview for May 1, 2026. Analysts expect $0.78 EPS and $1.70B revenue. Historical performance analysis and key metrics.
NAB.AX Stock Falls 0.72% on 30 Apr 2026 Ahead of Earnings
NAB.AX dropped 0.72% to A$39.88 on 30 Apr 2026. Earnings announcement scheduled for 3 May 2026. Market sentiment mixed.
GGII Stock Surges 9900% in April 2026 on Pink Sheets
GGII stock exploded 9900% to $0.0001 on April 30, 2026, with 945K volume. Green Globe International trades on PNK.
AMRX Earnings Preview: Amneal Pharmaceuticals Q1 2026 May 1
Amneal Pharmaceuticals (AMRX) reports Q1 2026 earnings May 1. Analysts expect $0.1691 EPS and $719.66M revenue. What to watch.